IP Library Granted Patent US 10,262,766
Granted Patent B2
US 10,262,766 · App. 14/316,271 · Granted Apr 16, 2019

Process of generating germanium

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,262,766
App. No.
14/316,271
Granted
Apr 16, 2019
Kind
B2
Abstract

The present disclosure generally relates to a new process for generating germanium-68 from an irradiated target body. The process includes irradiation of the target body followed by various extraction techniques to generate the germanium-68.

Claims (26)

1. A process for generating a radioisotope, the process comprising:

bombarding a target body including a starting material, wherein

the starting material is an alloy comprising gallium and nickel, and wherein

the bombardment of the starting material produces a radioisotope within the target body; then

allowing the bombarded target body to decay; then

stripping the intact bombarded target body with an acidic mixture to create a stripped solution, wherein the acidic mixture includes copper (II) nitrate trihydrate and nitric acid; then

extracting the radioisotope from the stripped solution using a non-polar solvent to remove the acidic mixture and create a non-polar solvent fraction including the radioisotope; then

washing the non-polar solvent fraction including the radioisotope; and then

extracting the radioisotope from the non-polar solvent fraction using water.

2. The process of claim 1 , wherein the radioisotope is germanium-68.

3. The process of claim 1 , wherein the alloy includes from about 10% to about 80% gallium, by weight of the alloy.

4. The process of claim 1 , wherein the alloy includes from about 60% to about 75% gallium and from about 25% to about 40% nickel, by weight of the alloy.

5. The process of claim 1 , wherein the target body is bombarded by a particle accelerator.

6. The process of claim 5 , wherein the particle accelerator includes a cyclotron.

7. The process of claim 1 , wherein the non-polar solvent fraction is washed with HCI.

8. The process of claim 1 , wherein the non-polar solvent is selected from the group consisting of heptane, hexane, cyclohexane, pentane and carbon tetrachloride.

9. A method of using a target body to produce germanium-68, the method comprising:

bombarding a target body including a gallium-nickel alloy, wherein the bombardment of the gallium-nickel alloy produces a germanium radioisotope within the target body; then

allowing the bombarded target body to decay; then

stripping the intact bombarded target body with an acidic mixture to create a stripped solution, wherein the acidic mixture includes copper (II) nitrate trihydrate and nitric acid; then

extracting the germanium radioisotope from the stripped solution using a non-polar solvent to remove the acidic mixture and create a non-polar solvent fraction including the germanium radioisotope; then

washing the non-polar solvent fraction including the germanium radioisotope; and then

extracting the germanium radioisotope from the non-polar solvent fraction using water.

10. The method of claim 9 , wherein the non-polar solvent is selected from the group consisting of heptane, hexane, cyclohexane, pentane and carbon tetrachloride.

11. The method of claim 9 , wherein the alloy includes from about 60% to about 75% gallium and from about 25% to about 40% nickel, by weight of the alloy.

12. The method of claim 9 , wherein the non-polar solvent fraction is washed with HCI.

Assignments (5)
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 039237, FRAME 0147 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.); MALLINCKRODT CARRIBEAN, INC.; MALLINCKRODT US POOL LLC; MNK 2011 LLC (F/K/A MALLINCKRODT INC.); LUDLOW LLC (F/K/A LUDLOW CORPORATION); CNS THERAPEUTICS, INC.; MALLINCKRODT ENTERPRISES HOLDINGS LLC (F/K/A MALLINCKRODT ENTERPRISES HOLDINGS, INC.); MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS LLC (F/K/A MALLINCKRODT BRAND PHARMACEUTICALS, INC.); MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC.; MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC (F/K/A VTESSE INC.); MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING D.A.C.); INFACARE PHARMACEUTICAL CORPORATION; ST SHARED SERVICES LLC; THERAKOS, INC.; IKARIA THERAPEUTICS LLC; INO THERAPEUTICS LLC
Reel/Frame 065610/0902 →
RELEASE OF SECURITY INTEREST Recorded Jan 31, 2017
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: MALLINCKRODT NUCLEAR MEDICINE LLC
Reel/Frame 041131/0213 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 13, 2016
From: MALLINCKRODT LLC
To: MALLINCKRODT NUCLEAR MEDICINE LLC
Reel/Frame 039149/0234 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Jul 1, 2016
From: MALLINCKRODT LLC
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 039237/0147 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2014
From: UHLAND, WILLIAM C.; PIPES, DAVID WAYNE; PERRIGO, MELISSA DIANNE
To: MALLINCKRODT LLC
Reel/Frame 033613/0317 →